TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) has named Ramona L. Walls, Ph.D., as Executive Director of Data Science within C-Path’s Data Collaboration Center (DCC).Continue reading
Category Archives: AZBio News
The IRA is now law. What comes next?
AZBio President & CEO, Joan Koerber-Walker provides a brief overview of the provision of the Inflation Reduction act of 2022 (The IRA) from the patient and health innovation perspective and is then joined by health innovator and drug developer, Dr. Steven J. Potts, for a discussion of the potential unintended consequences of some provisions of The IRA relating to the future health innovation landscape.Continue reading
The Tissue Reference Group at the FDA, Recognizes BioLab Sciences Membrane Wrap – Hydro™ as an HCT/P
The unique amniotic membrane allograft aids in the covering and protection of wounds
Dr. Curiel-Lewandrowski Accepted into Leadership Fellowship
Clara Curiel-Lewandrowski, MD, FAAD, professor of medicine and chief of the Division of Dermatology in the UArizona College of Medicine – Tucson has been accepted into the Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) program.Continue reading
AZMN Launches Capital Campaign to Support New Virtual Cancer Caregivers Education Program
The Virtual Cancer Caregivers Education Programs, VCCEP® address the challenges faced by cancer caregivers. Delivered online, the VCCEP includes a ‘learning center’ that integrates 15 years of successful cancer caregiver workshops and training, including knowledge and perspectives from cancer patients, cancer caregivers and cancer care professionals.Continue reading
AZBio to Honor Ten Arizona Legislators as Trailblazers in 2022
The 2022 AZBio Trailblazer Honorees are: Senator Nancy Barto, Senator Sonny Borrelli, Senator Sean Bowie, Senator David Gowan, Senator Sine Kerr, Senator T.J. Shope, Representative Regina Cobb, DDS , Representative Daniel Hernandez, Jr., Representative Amish Shah, MD, and Representative Justin Wilmeth.Continue reading
C-Path’s Transplant Therapeutics Consortium Receives EMA Draft Qualification Opinion for iBox Scoring System
The draft EMA qualification opinion is available for public consultation until November 17, 2022
Secondary endpoint prognostic for allograft loss to catalyze development of novel therapies intended to improve long-term outcomes for kidney transplant recipientsContinue reading
The Mayo Clinic and Arizona State University Pitch Competition
The Mayo Clinic and Arizona State University Alliance jointly launched the Scorpion Tank, a healthcare pitch competition.Continue reading
Vidium Animal HealthⓇ and Torigen Pharmaceuticals Partner to Increase Accessibility of Advanced Cancer Care for Canine Patients
PHOENIX—October 11, 2022—Vidium Animal Health announced today that it has partnered with Torigen Pharmaceuticals, an animal health biologics company, to offer genomic testing and precision medicine to more veterinarians. By opening up the use of personalized, precision medicine to the veterinary marketplace, Vidium and Torigen are providing specialists and general practicing veterinarians with more options to advance the care of dogs with cancer.Continue reading
BIO Announces Appointment of Interim CEO
The Biotechnology Innovation Organization (BIO) – the world’s largest science and public advocacy organization, representing 1,000 members — announced today that Rachel King, co-founder and former CEO of GlycoMimetics, Inc., has agreed to serve as interim President and CEO. King’s appointment follows Dr. Michelle McMurry-Heath stepping down as President and CEO to serve as an Advisor to the Executive Committee of the BIO Board of Directors. The organization is searching for a full-time successor.Continue reading